Compare AbCellera Biologics Inc (ABCL) vs Icl Group Ltd (ICL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Icl Group Ltd — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Icl Group Ltd trades at $5.45 (market cap $6.94B). The key difference: Icl Group Ltd is far larger — about 2.3× AbCellera Biologics Inc's market cap, and Icl Group Ltd pays a 3.86% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | ICL | |
|---|---|---|
Market Cap | $2.99B | $6.94B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $6.84 |
52-Week Low | $2.78 | $4.80 |
Enterprise Value | $2.58B | $9.58B |
Dividend Yield | — | 3.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →
